Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2011-06-21
2011-06-21
Woodward, Cherie M (Department: 1647)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S141100
Reexamination Certificate
active
07964194
ABSTRACT:
It is possible to inhibit inflammatory processes by administration of antibodies to chemokines. Identification of chemokines which are over-produced makes it possible to block specific chemokine activity using antibodies to the over-expressed chemokines.
REFERENCES:
patent: 6329510 (2001-12-01), Qin et al.
patent: 2003/0166589 (2003-09-01), Karin
patent: WO 02/015932 (2002-02-01), None
Angostini et al., (Am J Path. May 2001:158(5):1703-1711).
International Search Report, Form PCT/ISA/210 of International Application No. PCT/US03/36556.
Lillard, Jr. James W.
Singh Shailesh
Singh Udai P.
Stiles Jonathan K.
Andrews & Kurth LLP
Morehouse School of Medicine
Wang Ping
Woodward Cherie M
LandOfFree
Anti-chemokine and associated receptor antibodies and uses... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-chemokine and associated receptor antibodies and uses..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-chemokine and associated receptor antibodies and uses... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2657773